Horse /

Breed profile · FDA CVM July 2026 extract

Warmblood (unspecified) adverse-event record

Adverse-event filings for Warmblood (unspecified) (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

Verify with FDA CVM →
#138 of 510
by report volume (all breeds)
541
FDA CVM reports on file
7.0%
death-coded share of reports
#83 of 275
by death-coded share (≥50 reports)

How the 541 reports break down

By recorded gender -- every report on file for Warmblood (unspecified), no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 73 54.75 36.5 18.25 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Warmblood (unspecified) drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Warmblood (unspecified) ranks #138 of 510 by total reports (541) and #83 of 275 by death-coded share (7.0%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#138
This breed, reports of 510
#83
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Warmblood (unspecified) has 541 reports now versus 528 in that prior snapshot: 13 more (2.5%).

Report change
+13
Death-coded reports
+0
Death-coded share
−0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Warmblood (unspecified) changes

Total Reports

541

Above-median volume

Deaths Reported

38

of 541 reports

Death-coded share of reports

7.0%

Above-median death-coded share

Avg Age at Report

12.8 yr

471.0 kg avg weight

Breed Safety Scorecard

F (36/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
7.0%

Share of reports coded as a fatality

Euthanasia rate F
5.0%

Share of reports resulting in euthanasia

Full recovery rate A
37.5%

Share of reports coded "Recovered/Normal"

5-year trend F
+31%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Warmblood (unspecified) death-coded reports 7.0%
Cross-breed median

7.0% of 541 warmblood (unspecified) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Warmblood (unspecified)'s death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

7% 70th percentile Higher share than 70% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Warmblood (unspecified) 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 471.0 kg (1038.6 lbs)

Top Reported Reactions

Lack of efficacy - NOS 109
INEFFECTIVE, GASTRIC ULCER(S) 81
Injection site swelling 52
Colic 41
Fever 31
Injection site pain 29
Lethargy (see also Central nervous system depression in 'Neurological') 26
Death by euthanasia 25

Most Referenced Drugs

Omeprazole 180
Ceftiofur Crystalline Free Acid 67
Pergolide Mesylate 51
Sucralfate 48
Polysulfated Glycosaminoglycan 41
Detomidine Hydrochloride 40
Hyaluronate Sodium 21
Misoprostol 18

Outcome Breakdown

Recovered/Normal
203 (37.5%)
Outcome Unknown
170 (31.4%)
Ongoing
119 (22.0%)
Euthanized
27 (5.0%)
Recovered with Sequela
12 (2.2%)
Died
11 (2.0%)

Gender Distribution

Male 352 (65.1%)
Female 159 (29.4%)
Unknown 23 (4.3%)
Mixed 7 (1.3%)

Reports by Year

Year Reports Trend
2010 1
2011 3
2012 15
2013 24
2014 20
2015 34
2016 22
2017 31
2018 44
2019 37
2020 42
2021 36
2022 45
2023 55
2024 73
2025 47
2026 12

Warmblood (unspecified): high death-coded share in the FDA CVM extract

Signature read: 541 reports place Warmblood (unspecified) in the upper third of breed filing volume (#138 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Warmblood (unspecified) sits at #138 of 510 by report volume among all breeds and #4 of 55 among horse breeds, with 541 reports and 38 (7.0%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #83 of 275. Mean age at report: 12.8 years, average weight 471.0 kg (1038.6 lbs).

Top reported signs: Lack of efficacy - NOS (109), INEFFECTIVE, GASTRIC ULCER(S) (81), Injection site swelling (52). Most-referenced drug: Omeprazole (180 reports), followed by Ceftiofur Crystalline Free Acid (67) and Pergolide Mesylate (51).

Outcome coding on 542 status-recorded reports is dominated by Recovered/Normal (37.5%). Annual submissions ranged 1-2,026 across 17 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Arab
467 reports · 9.6% death-coded
Paint
386 reports · 13.7% death-coded
Horse (other)
296 reports · 9.8% death-coded
Crossbred Equine/horse
190 reports · 7.9% death-coded
Tennessee Walking Horse
186 reports · 12.9% death-coded
Warmblood - Dutch
184 reports · 2.7% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Warmblood (unspecified) drawn from openFDA outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (7.0% death-coded here).

Snowshoe 7.0% · Cat Spaniel - American Water 7.0% · Dog Newfoundland 7.0% · Dog American Pit Bull Terrier 7.0% · Dog

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Warmblood (unspecified)? ▼
There are 541 adverse event reports involving Warmblood (unspecified) in the FDA database, of which 38 were death-coded (7.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Warmblood (unspecified) ranks #138 of 510 by report volume among all breeds PlainBreed indexes (#4 of 55 among horse breeds).
Where does Warmblood (unspecified) sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Warmblood (unspecified) is #138 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #4 of 55. Among breeds with at least 50 reports, its death-coded share ranks #83 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Warmblood (unspecified)? ▼
The most commonly reported adverse reactions for Warmblood (unspecified) are Lack of efficacy - NOS (109 reports), INEFFECTIVE, GASTRIC ULCER(S) (81 reports), Injection site swelling (52 reports), Colic (41 reports), Fever (31 reports).
What drugs are most frequently associated with Warmblood (unspecified) adverse events? ▼
The drugs most frequently referenced in Warmblood (unspecified) adverse event reports are Omeprazole (180 reports), Ceftiofur Crystalline Free Acid (67 reports), Pergolide Mesylate (51 reports), Sucralfate (48 reports), Polysulfated Glycosaminoglycan (41 reports).
What is the average age of Warmblood (unspecified) in adverse event reports? ▼
The average age of Warmblood (unspecified) at the time of adverse event reports is 12.8 years, with an average weight of 471.0 kg (1038.6 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Warmblood (unspecified) (Horse), extract as of July 2026 extract. 541 reports · 38 death-coded (7.0% of reports, not a mortality rate) · #138 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →